Related Experiment Videos

["Atherosclerosis-index" (LDL/HDL): risk indicator in lipid metabolism disorders]

Medizinische Klinik
|February 15, 1980
PubMed

Insights

The atherosclerosis index, calculated from lipid levels, is the most reliable indicator of cardiovascular risk in hyperlipoproteinemia patients. Triglyceride levels showed the widest variation during the six to twelve-month follow-up.

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Clinical Biochemistry

Context:

  • Hyperlipoproteinemia management involves diet and lipid-lowering medications.
  • Patient monitoring is crucial for assessing treatment efficacy and cardiovascular risk.
  • Longitudinal studies are essential for understanding disease progression and treatment outcomes.

Purpose:

  • To evaluate the reliability of various serum lipid coefficients as indicators of cardiovascular risk.
  • To identify the most significant predictor of increased risk in patients with hyperlipoproteinemia.
  • To assess the variability of lipid profiles during a six to twelve-month treatment period.

Summary:

  • This study followed patients with hyperlipoproteinemia undergoing diet and drug therapy for six to twelve months.
  • Serum concentrations of total cholesterol, triglycerides, phospholipids, HDL-cholesterol, and LDL-cholesterol were measured.
  • The LDL/HDL ratio, termed the "atherosclerosis-index," emerged as the most dependable indicator of elevated cardiovascular risk (7.9 +/- 1.3%).
  • Triglyceride concentrations exhibited the greatest variability (20.1 +/- 3.0%).

Impact:

  • Identifies the "atherosclerosis-index" as a key biomarker for cardiovascular risk stratification in hyperlipoproteinemia.
  • Provides insights into the variability of lipid parameters, aiding in treatment monitoring and adjustment.
  • Contributes to a better understanding of lipid management strategies for reducing cardiovascular disease.

Related Concept Videos